ArticleBMC pulmonary medicine2024

Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations.

Arzu Yorgancıoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.